Rising incidences of adverse drug reactions and resistance to the treatments in patients, coupled with high investment in the study of pharmacogenomics, is driving the market growth.
The Global Pharmacogenomics (PGx) Market size is forecasted to reach USD 11.01 billion from USD 5.66 billion in 2019, delivering a CAGR of 8.7% through 2027. The market growth is driven by...
The Global Pharmacogenomics Market research report gives point to point breakdown along with the data of Pharmacogenomics market’s analytical study, regional analysis, growth factors and leading companies. The research report about the market provides the data about the aspects which drive the expansion of Pharmacogenomics industry. The Pharmacogenomics market consists of large...
The Pharmacogenomics Market in 2023 is US$ 15.61 billion, and is expected to reach US$ 36.8 billion by 2031 at a CAGR of 11.30%.
FutureWise Research published a report that analyzes Pharmacogenomics Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the market trends...
The global pharmacogenomics services market is expected to witness high growth, attributing to the global increase in the prevalence of infectious diseases and various types of cancers, increase in adoption of personalized medicine shifting the paradigm from reaction to prevention, rise in the rate of adverse drug reactions, and surge in the usage of pharmacogenomics for drug discovery and...
Pharmacogenomics has increasingly become an area of interest for the research community, which has the potential to revolutionize precision care, largely due to the studies that focus on the discovery of biomarkers associated with a particular medical condition. This study aims at deciphering the potential of pharmacogenomics services and their larger role in bolstering the current era of...
Rising incidences of adverse drug reactions and resistance to the treatments in patients, coupled with high investment in the study of pharmacogenomics, is driving the market growth.
The Global Pharmacogenomics specific Market size is forecasted to reach USD 11.01 billion from USD 5.66 billion in 2019, delivering a CAGR of 8.7% through 2027. The market growth is driven...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian